Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseases - sprookjes - yvandenbroek - TriplyDB

Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseases

Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseases

http://www.wikidata.org/entity/Q26863260

about

Bacillus calmette-guerin infection in NADPH oxidase deficiency: defective mycobacterial sequestration and granuloma formation.Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections.Live attenuated S. Typhimurium vaccine with improved safety in immuno-compromised mice.Differential Mycobacterium bovis BCG vaccine-derived efficacy in C3Heb/FeJ and C3H/HeOuJ mice exposed to a clinical strain of Mycobacterium tuberculosis.Vaccine against tuberculosis: what's new?Clinical characteristics and immunogenetics of BCGosis/BCGitis in Chinese children: a 6 year follow-up study Novel GMO-Based Vaccines against Tuberculosis: State of the Art and Biosafety Considerations Adverse reactions to Mycobacterium bovis bacille Calmette-Guérin vaccination against tuberculosis in Iranian children.Understanding immune protection against tuberculosis using RNA expression profiling Management and outcome of Bacille Calmette-Guérin vaccine adverse reactions.Post-Vaccination Disseminated Bacillus Calmette Guerin Infection Among Children in Southern Iran.Disseminated Bacillus Calmette-Guérin (BCG) infection following allogeneic hematopoietic stem cell transplant in a patient with Bare Lymphocyte Syndrome type II.CLINICAL MANAGEMENT OF LOCALIZED BCG ADVERSE EVENTS IN CHILDREN.Pulmonary manifestations of chronic granulomatous disease.Fifteen-minute consultation: Bacillus Calmette-Guérin abscess and lymphadenitis.Molecular diagnosis of primary immunodeficiency diseases in a developing country: Iran as an example.Challenges in mucosal vaccines for the control of infectious diseases.Primary immunodeficiencies: a decade of shifting paradigms, the current status and the emergence of cutting-edge therapies and diagnostics.Important differences in the diagnostic spectrum of primary immunodeficiency in adults versus children.Vaccine research and development: tuberculosis as a global health threat.Fulminant BCG Disease in a 7 Month Old Healthy Male Infant.Resolution of Primary Immune Defect in 22q11.2 Deletion Syndrome.Primary Immunodeficiency Diseases in Oman: 10-Year Experience in a Tertiary Care Hospital.Interferon-gamma reduces the proliferation of M. tuberculosis within macrophages from a patient with a novel hypomorphic NEMO mutation.Clinical and Genotypic Spectrum of Chronic Granulomatous Disease in 71 Latin American Patients: First Report from the LASID Registry.BCGitis and BCGosis in children with primary immunodeficiency - imaging characteristics.Clinical features and genetic analysis of 20 Chinese patients with X-linked hyper-IgM syndrome.Bcgitis and vaccine-derived poliovirus infection in a patient with a novel deletion in RAG1 binding site.Adverse Reactions Due to the Bacillus Calmette-Guerin Vaccine: Twenty Tunisian Cases.Use of the Human Vaccine, Bacillus Calmette Guérin in Deer Cutaneous Manifestations of Primary Immunodeficiency Diseases in Tunisian Children

P2860

Q34134720-E14A2FF0-D76C-4C06-8F92-ACED0D5D7707 Q34423996-9C6AD5A5-6E1F-4930-B0D2-239D06BC9836 Q34429033-67D0AE56-CA5C-4DAA-AD30-6205A35BD453 Q34784945-2B024246-F0EA-4070-BAC5-4202FBD0ED67 Q35101472-46072506-7174-4304-9700-8226F122B5FA Q35145571-7EC7F6B9-4196-49D6-A162-B15F77C7FBD6 Q35826779-7DDB8850-41B5-4553-875B-71339FBAB935 Q35916231-316C9B49-0A14-4055-ADC3-B07D76C3313D Q36092310-C2F98C7F-9952-4832-B7EA-A46C6E9D50F6 Q36092315-7B1F6C85-8181-453F-887D-15C67211AE0C Q36542672-601715D0-0DE4-41B1-970A-6ADC9D9AF192 Q36926207-1B89A8E2-71DB-4D52-8021-C0C0EC44C7C1 Q37395397-DAFFECED-2EE4-49BE-A59B-4B228112AAC3 Q38079835-805118E3-1398-4CDE-9136-19C24C2E0BCE Q38161324-2B073181-2342-4C72-864F-14EEB4FCE80F Q38180715-051342AE-7A70-4954-9C3C-C8A0D56ED668 Q38219010-6F706678-41A6-4BD2-BF7F-2D349C2EFEB3 Q38289442-30B1E119-A3E1-4192-9684-0BE51C8AFA29 Q38306637-706C6EA0-474C-4693-938A-A4B8E1E79CBB Q40059597-0F06B502-46F1-429F-8231-706B2F209731 Q40136981-E1325615-51DD-44CC-AD65-DAC1AE7C4B1D Q40242997-A7CCEB4C-14D9-4CCB-9E9F-657E083F0688 Q40517818-58A241F9-CAD7-496D-9E56-F801C07021F1 Q40620876-B1252E0B-6CF7-4736-A0A0-EA55A122917F Q40725842-8A18FC35-3BC5-4554-BC18-8C267DB4EB7D Q40958414-5924E9F9-D7D0-4961-B745-EBDAE4E37E2D Q41741675-303F4C13-FBDB-4523-A889-4D387255EFF9 Q46851078-0919211A-F3D8-4EF6-ABF9-CE8F3F376BF3 Q52661810-89617BF9-10B1-48D0-8923-CC9E4A69007F Q57817663-4667AFF0-5F6F-4835-8BF6-AC1E792DEDFE Q58701091-BA0077C0-CF24-4A9A-888A-54EB5D96E0C3

P2860

Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseases

http://www.wikidata.org/entity/Q26863260

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Bacillus Calmette-Guérin (BCG) ...... mary immunodeficiency diseases

@ast

Bacillus Calmette-Guérin (BCG) ...... mary immunodeficiency diseases

@en

Bacillus Calmette-Guérin (BCG) ...... mary immunodeficiency diseases

@nl

type

label

Bacillus Calmette-Guérin (BCG) ...... mary immunodeficiency diseases

@ast

Bacillus Calmette-Guérin (BCG) ...... mary immunodeficiency diseases

@en

Bacillus Calmette-Guérin (BCG) ...... mary immunodeficiency diseases

@nl

prefLabel

Bacillus Calmette-Guérin (BCG) ...... mary immunodeficiency diseases

@ast

Bacillus Calmette-Guérin (BCG) ...... mary immunodeficiency diseases

@en

Bacillus Calmette-Guérin (BCG) ...... mary immunodeficiency diseases

@nl

P1433

Q26863260-D1E4CBF1-3060-4DAC-A4F1-0A2F44C54CC4

P1476

Q26863260-8DF5B24F-D59D-4D56-8FFF-2005B134FFE1

P2093

Q26863260-7EB6CB85-40F5-414A-BF64-E40C6FE7B294

Q26863260-B127036E-E856-4E52-9836-DB71AD8ABE6F

Q26863260-D70DB1B2-599E-433E-8E04-8D0792F18484

P2860

Q26863260-001A991C-FA4F-4E8F-9D30-8A40E5A48716

Q26863260-01E44318-6108-4A58-8ECB-93209543E4A1

Q26863260-03F56C4C-6BB3-479E-9E29-073E4178B68A

Q26863260-04F669F0-9BB1-4A85-AD97-6D9A0AAE61B0

Q26863260-0723D12F-FDCE-4029-BBB7-F510FA37E680

Q26863260-0A0A7444-8339-4BC8-8F0B-4893834AE4B7

Q26863260-0E740E62-A086-47D4-A95A-AEA6F3D3446A

Q26863260-18EADFD2-EF37-4212-8500-759BE1498892

Q26863260-193FF0AC-9064-4EA5-9F4D-90008F091B39

Q26863260-1C5F7E15-32BC-4A38-9AF0-60EE8D072948

P304

Q26863260-00C4AF79-0694-4C35-A593-CCC3B706D3A7

P31

Q26863260-AAAEA759-4154-4027-B4E1-E7E797161324

P3181

Q26863260-9C339BCC-47F4-48D2-B449-65D30D76F729

P356

Q26863260-645DD833-EABB-4501-8103-7F5B7BD2CD94

P407

Q26863260-0558372B-BA45-484A-90F3-00FA90CCBB0F

P433

Q26863260-0159FEB3-DB3C-4389-BA30-3E24A2BE51EE

P478

Q26863260-C5FD0E0E-F312-4D48-A1F2-2C2FE05D56A2

P50

Q26863260-1C7646CE-ECA0-4E26-8F43-4DC4C0C1F090

Q26863260-8CBEABB5-79FC-492C-A065-0E7D437FB30D

P577

Q26863260-95420D7F-8450-4EB1-8BAA-9BE710CA24FF

P698

Q26863260-D6EDBEAF-4913-49BE-B764-7A56E892FF67

P932

Q26863260-60B9514F-5044-4F4D-B79E-917CB7431CAC

P3181

P356

J.JINF.2012.03.012

P1433

Journal of Infection

P1476

Bacillus Calmette-Guérin (BCG) ...... mary immunodeficiency diseases

@en

P2093

Sayna Norouzi

http://www.w3.org/2001/XMLSchema#string

Sergio D. Rosenzweig

http://www.w3.org/2001/XMLSchema#string

Setareh Mamishi

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic granulomatous disease: the European experience

Killing activity of neutrophils is mediated through activation of proteases by K+ flux

Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients

Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee

Oxidative innate immune defenses by Nox/Duox family NADPH oxidases

Interleukin-12 receptor beta1 deficiency in a patient with abdominal tuberculosis

X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling

IFN regulatory factor 8 mediates apoptosis in nonhemopoietic tumor cells via regulation of Fas expression

First report of clinical, functional, and molecular investigation of chronic granulomatous disease in nine Jordanian families

A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection

P304

543-54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2682114

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.JINF.2012.03.012

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P50

Asghar Aghamohammadi

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22430715

http://www.w3.org/2001/XMLSchema#string

P932

4792288

http://www.w3.org/2001/XMLSchema#string